NATHANIEL HAGEDORN

Profile

First Name

: NATHANIEL

Middle Name

:

Last Name

: HAGEDORN

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-08-21 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-08-21 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2025-12-18 
D
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-02 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D/A
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-08-21 
D
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-30 
D
COMMERCIAL 
 
$5,000,001 - $25,000,000 
Equity 
2024-10-15 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-07-28 
D/A
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D/A
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2023-11-16 
D/A
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-07-28 
D/A
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D/A
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D/A
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D/A
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D/A
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-12-08 
D/A
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D/A
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D/A
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D/A
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D/A
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D/A
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D
OTHER REAL ESTATE 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-24 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-24 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-25 
D
COMMERCIAL 
 
$5,000,001 - $25,000,000 
Equity 
2021-11-05 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-25 
D
COMMERCIAL 
 
$5,000,001 - $25,000,000 
Equity 
2021-09-01 
D/A
RESIDENTIAL 
 
$5,000,001 - $25,000,000 
Equity 
2021-07-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-03 
D
RESIDENTIAL 
 
$5,000,001 - $25,000,000 
Equity 
2021-07-23 
D/A
COMMERCIAL 
 
$5,000,001 - $25,000,000 
Equity 
2021-07-02 
D
COMMERCIAL 
 
$5,000,001 - $25,000,000 
Equity 
2021-07-02 
D
COMMERCIAL 
 
$5,000,001 - $25,000,000 
Equity 
2021-07-02 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-04 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-04 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-08 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-05-27 
D
COMMERCIAL 
 
$5,000,001 - $25,000,000 
Equity 
2020-08-11 
D
RESIDENTIAL 
 
$5,000,001 - $25,000,000 
Equity 
2020-07-24 
D
COMMERCIAL 
 
$25,000,001 - $100,000,000 
Equity 
2019-11-18 
D/A
COMMERCIAL 
 
$5,000,001 - $25,000,000 
Equity 
2019-10-21 
D
COMMERCIAL 
 
$5,000,001 - $25,000,000 
Equity 
2019-10-21 
D
COMMERCIAL 
 
$5,000,001 - $25,000,000 
Equity 
2019-08-29 
D
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-13 
D
COMMERCIAL 
 
$5,000,001 - $25,000,000 
Equity 
2019-03-28 
D
COMMERCIAL 
 
$5,000,001 - $25,000,000 
Equity 
2017-05-19 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-06-04 
D
COMMERCIAL 
 
$25,000,001 - $100,000,000 
Equity 
2015-03-13 
D
RESIDENTIAL 
 
NOT APPLICABLE 
Equity 
2014-05-09 
D
COMMERCIAL 
 
NOT APPLICABLE 
Equity 
2013-06-15 
D
RESIDENTIAL 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-01 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-24 
D
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-01